The electrical signals of neurons are fundamentally dependent on voltage-gated sodium channels (VGSCs), which are responsible for the rising phase of the action potential. An array of naturally occurring and synthetic neurotoxins have been identified that modify the gating properties of VGSCs. Using murine neocortical neurons in primary culture, we have compared the ability of VGSC gating modifiers to evoke Na ϩ influx. 
tridine and aconitine, and the pyrethroid deltamethrin were somewhat lower with maximal [Na ϩ ] i increments of less than 40 mM. The rank order of efficacy of sodium channel gating modifiers was brevetoxin (PbTx)-1 Ͼ PbTx-desoxydioxolane Ͼ batrachotoxin Ͼ antillatoxin Ͼ PbTx-2 ϭ PbTx-3 Ͼ PbTx-3␣-naphthoate Ͼ veratridine Ͼ deltamethrin Ͼ aconitine Ͼ gambierol. These data demonstrate that the ability of sodium channel gating modifiers to act as partial agonists is shared by compounds acting at both neurotoxin sites 2 and 5. The concentration-dependent increases in [Na ϩ ] i produced by PbTx-2, antillatoxin, veratridine, deltamethrin, aconitine, and gambierol were all abrogated by tetrodotoxin, indicating that VGSCs represent the sole pathway of Na ϩ entry after exposure to gating modifier neurotoxins.
The electrical signals of neurons are fundamentally dependent on voltage-gated sodium channels (VGSCs), which are responsible for the rising phase of the action potential. These ion channels represent the molecular target for an array of naturally occurring and synthetic neurotoxins that specifically bind to at least six distinct receptor sites on the sodium channel ␣-subunit (Catterall et al., 2007) . These toxins include hydrophilic toxins such as tetrodotoxin, saxitoxin, and -conotoxin (receptor site 1); lipid-soluble alkaloid toxins, including batrachotoxin, veratridine, acotinine, and grayanotoxin (receptor site 2); polypeptide toxins, such as ␣-scorpion toxins, sea anemone toxins, and some spider toxins (receptor site 3); ␤-scorpion toxins (receptor site 4); brevetoxins (PbTxs) and ciguatoxins originating from the marine dinoflagellates Karenia brevis and Gambierdiscus toxicus, respectively (receptor site 5); and ␦-conotoxins (receptor site 6). In addition, pyrethroid insecticides act at a site distinct from these better characterized neurotoxin receptor sites on the sodium channel ␣-subunit to enhance channel activity by shifting activation to more negative membrane potentials as well as by inhibiting inactivation (Ruigt et al., 1987) . More recently, a structurally unique lipopeptide toxin, antillatoxin, produced by the marine cyanobacterium, Lyngbya majuscula, has been demonstrated to be a potent VGSC activator at yet another distinct receptor site (Berman et al., 1999; Li et al., 2001) .
The lipid-soluble toxins acting at neurotoxin receptor sites 2 and 5 have been characterized as allosteric modulators of sodium channel function (Catterall et al., 2007) . These toxins bind at topologically distinct sites that favor the open state of the sodium channel and display complex allosteric interactions. Batrachotoxin is a neurotoxin that activates site 2 on the ␣-subunit of VGSC. Batrachotoxin produces a shift in the threshold for VGSC activation to more hyperpolarized membrane potentials, resulting in persistent channel opening at resting potential (Wang and Wang, 2003) . Batrachotoxin and other site 2 ligands also inhibit VGSC inactivation, further contributing to persistent channel opening (Wang and Wang, 2003) .
The specific binding of [ 3 H]batrachotoxin to neurotoxin site 2 is sensitive to conformational changes induced by the binding of toxins to other sites on the ␣-subunit . The binding of [ 3 H]batrachotoxin to neurotoxin site 2 is enhanced by the interaction of brevetoxins with site 5 (Sharkey et al., 1987) . Using reconstituted VGSC preparations, the most potent brevetoxin analog, PbTx-1, enhanced [ 3 H]batrachotoxin binding greater than 5-fold (Trainer et al., 1993) . It is noteworthy that the less toxic brevetoxin, PbTx-9, caused only a small increase in [ 3 H]batrachotoxin binding. These results are consistent with brevetoxin analogs possessing distinct efficacies as activators of neurotoxin site 5 (LePage et al., 2003) . Lipophilic toxins, in addition to batrachotoxin, that act at neurotoxin site 2 include the alkaloids veratridine and aconitine (Cestèle and Catterall, 2000) . These ligands interact with neurotoxin site 2 in a mutually exclusive manner and increase Na ϩ permeability of neuroblastoma cells to different extents at saturation (Catterall, 1975) . Sodium influx studies using rat brain synaptosomes have confirmed that batrachotoxin, veratridine, and aconitine activate VGSCs by an interaction with a common receptor site 2, at which batrachotoxin is a full agonist, and aconitine and veratridine are partial agonists (Tamkun and Catterall, 1981) . These actions of sodium channel activators have been quantitatively described by an allosteric model that assumes toxin high-affinity binding to activated sodium channels with a shift in the conformational equilibrium toward the activated or open state (Catterall, 1977a) .
VGSCs are vital for normal central nervous system functioning, and recent studies have additionally shown that intracellular sodium concentration ([Na ϩ ] i ) may act as a signaling molecule. Yu and Salter (1998, 1999) reported that increases in intracellular Na ϩ increase NMDA receptor mediated whole-cell currents and NMDA receptor single-channel activity by increasing both open probability and mean open time of the channel. Using veratridine, these investigators demonstrated that influx of Na ϩ through a tetrodotoxin (TTX)-sensitive VGSC was sufficient to produce potentiation of NMDA channel activity. Moreover, previous studies have found that PbTx-2 augments NMDA receptor-mediated Ca 2ϩ influx in both spontaneously oscillating mature and nonoscillatory immature cerebrocortical neurons (Dravid at al., 2005) . PbTx-2 also enhanced the effect of bath-applied NMDA on extracellular signal-regulated kinase 2 activation.
Therefore, we have quantified the potencies and efficacies of an array of lipophilic VGSC gating modifiers by measuring Na ϩ influx in murine neocortical neurons. This was accomplished using the Na ϩ -sensitive fluorescent dye, sodiumbinding benzofuran isophthalate (SBFI). Application of this assay to primary cultures of neurons afforded a highly quantitative assessment of the increments in neuronal sodium level produced by gating modifier toxins.
Materials and Methods
Materials. Trypsin, penicillin, streptomycin, heat-inactivated fetal bovine serum, horse serum, and soybean trypsin inhibitor were obtained from Atlanta Biologicals (Norcross, GA). Minimum essential medium, DNase, poly-L-lysine, cytosine arabinoside, veratridine, aconitine, and deltamethrin were from Sigma-Aldrich (St. Louis, MO), and batrachotoxin was from BIOMOL Research Laboratories (Plymouth Meeting, PA). The fluorescent dye SBFI-acetoxymethyl ester and Pluronic acid F-127 were obtained from Invitrogen (Carlsbad, CA). Brevetoxins-1, -2, and -3 were isolated and purified from K. breve cultures at the Center for Marine Sciences at the University of North Carolina (Wilmington, NC). The semisynthetic brevetoxin analogs were synthesized as described elsewhere by Purkerson-Parker et al. (2000) . Gambierol was synthesized as described by Johnson et al. (2006) . Antillatoxin was authentic natural (Ϫ)-antillatoxin, isolated as described by Orjala et al. (1995) . The structures of all gating modifier toxins evaluated are depicted in Fig. 1 .
Neocortical Neuron Culture. Primary cultures of neocortical neurons were obtained from embryonic day 16 Swiss-Webster mice (LePage et al., 2005) . In brief, pregnant mice were euthanized by CO 2 asphyxiation, and embryos were removed under sterile conditions. Neocortices were collected, stripped of meninges, minced by trituration with a Pasteur pipette, and treated with trypsin for 20 min at 37°C. The cells were then dissociated by two successive trituration and sedimentation steps in soybean trypsin inhibitor and DNase containing isolation buffer, centrifuged, and resuspended in Eagle's minimal essential medium with Earle's salt and supplemented with 2 mM L-glutamine, 10% fetal bovine serum, 10% horse serum, 100 IU/ml penicillin, and 0.10 mg/ml streptomycin, pH 7.4. Cells were plated onto poly-L-lysine-coated 96-well (9-mm) clearbottomed, black-well culture plates (Corning Life Sciences, Acton, MA) at a density of 1.5 ϫ 10 5 cells/cm 2 and incubated at 37°C in a 5% CO 2 and 95% humidity atmosphere. Cytosine arabinoside (10 M) was added to the culture medium on day 2 after plating to prevent proliferation of non-neuronal cells. The culture media was changed both on days 5 and 7 using a serum-free growth medium containing neurobasal medium supplemented with B-27, 100 IU/ml penicillin, 0.10 mg/ml streptomycin, and 0.2 mM L-glutamine. Neocortical cultures were used in experiments between 8 and 9 days in vitro (DIV). All animal use protocols were approved by the Institutional Animal Care and Use Committee.
[Na ؉ ] i Measurement. The cells were washed four times with Locke's buffer (8.6 mM HEPES, 5.6 mM KCl, 154 mM NaCl, 5.6 mM glucose, 1.0 mM MgCl 2 , 2.3 mM CaCl 2 , 0.0001 mM glycine, pH 7.4) using an automated cell washer (Bio-Tek Instruments, Winooski, VT). The background fluorescence of each well in the plate was measured and averaged before dye loading. Cells were then incubated for 1 h at 37°C with dye loading buffer (100 l/well) containing 10 M SBFI-acetoxymethyl ester and 0.02% Pluronic F-127. After 1 h of incubation in dye-loading medium, cells were washed five times with Locke's buffer, leaving a final volume of 150 l in each well. The plate was then transferred to the plate chamber of a FLEXstation II (Molecular Devices, Sunnyvale, CA). Cells were excited at 340 and 380 nm, and Na ϩ -bound SBFI emission was detected at 505 nm. Fluorescence readings were taken once every 5 s for 60 s to establish the baseline, and then 50 l of neurotoxin containing solution (4ϫ) was added to each well from the compound plate at the rate of 26 l/s, yielding a final volume of 200 l/well. The cells were exposed to the VGSC gating modifiers for another 240 s. Full in situ calibration of the SBFI fluorescence ratio was performed as described previously (Diarra et al., 2001 ) using calibration media containing 0.6 mM MgCl 2 , 0.5 mM CaCl 2 , 10 mM HEPES, Na ϩ and K
ϭ 130 mM, 100 mM gluconate, and 30 mM Cl Ϫ (titrated with 10 mol/l KOH to pH 7.4). Gramicidin D (5 M) (Na ϩ ionophore), monensin (10 M) (Na ϩ /H ϩ carrier), and ouabain (100 M) (Na ϩ /K ϩ -ATPase inhibitor) were added to equilibrate the intracellular and extracellular sodium concentration. After five washes, the Locke's buffer was replaced by 150 l of sodium containing calibration solution (0 -130 mM). The plate was then loaded onto the FLEXstation chamber for recording of emitted fluorescence during excitation at 340 and 380 nm.
Data Analysis. The raw emission data at each excitation wavelength were exported to an Excel work sheet and corrected for background fluorescence. The SBFI fluorescence ratios (340:380) versus time were then analyzed, and time-response and concentration-response graphs were generated using GraphPad Prism software (GraphPad Software Inc., San Diego, CA). The EC 50 and maximal response values for VGSC gating modifiers were determined by nonlinear regression analysis using a logistic equation. In select experiments, SBFI fluorescence ratios were analyzed by one-way analysis of variance. A Dunnett's post hoc analysis was performed to compare these values for different treatments.
Results

Calibration of [Na
؉ ] i in Neocortical Neurons. To quantify VGSC gating modifier-induced [Na ϩ ] i elevation in neocortical neurons, the relationship between the radiometric SBFI signal and [Na ϩ ] i was established in situ. This in situ calibration is required inasmuch as SBFI, similar to the Ca 2ϩ indicator fura-2, displays different spectral properties in an intracellular environment than in a cell-free system. The emitted fluorescence intensities were recorded during excitation at 340 and 380 nm and were converted to a ratio (340:380) after background correction (Fig. 2a) . To convert the ratio of emitted SBFI signals into a [Na ϩ ] i value, the following equation (eq. 1) was used:
where ␤ is the ratio of the fluorescence of the free (unbound) dye to bound dye at the second excitation wavelength (380 nm), K d is the apparent dissociation constant of SBFI for Na ϩ , R is the background-subtracted SBFI fluorescence ratio, and R min and R max are the minimum and maximal fluorescence values, respectively. The data points relating [Na ϩ ] i to R were fitted by a three-parameter hyperbolic equation having the form:
where a and b are constants and equal to R max Ϫ R min and ␤K d , respectively (Diarra et al., 2001) . These data relating [Na ϩ ] i to R (Fig. 2b) were well described (r 2 ϭ 0.987) by eq. 2. The derived parameters were R min ϭ 1.460 Ϯ 0.012, a ϭ 2.950 Ϯ 0.029, and b ϭ 39.14 Ϯ 1.26. The value for R min obtained by this method was identical to the value of R min derived experimentally at [Na ϩ ] ϭ 0 mM. Therefore, the corresponding values for R max and ␤K d were R max ϭ 4.41 Ϯ 0.04 and ␤K d ϭ 39.14 Ϯ 1.26 mM.
Another method to derive the parameters for calibration of SBFI ratios is by a Hanes plot (Donoso et al., 1992; David et al., 1997; Diarra et al., 2001) . Therefore, we compared the values of R max and ␤K d obtained from a Hanes plot to those derived from the three-parameter hyperbolic fit. The equation was rearranged to generate a Hanes plot such that:
As shown in Fig. 2c Gating Modifier-Induced Sodium Influx 607 at ASPET Journals on July 9, 2017 jpet.aspetjournals.org dium as a putative regulator of NMDA receptor-mediated signaling, it was important to quantify VGSC gating modifier-induced elevation of [Na ϩ ] i (Yu, 2006) . Therefore, we assessed gating modifier-induced elevation of [Na ϩ ] i in neocortical neurons loaded with SBFI. Fluorescence emitted during excitation at 340 nm was unaffected by changes in [Na ϩ ] i . As depicted in Fig. 3 , exposure to PbTx-2 (300 nM) produced a rapid decrease in SBFI fluorescence emitted by excitation at 380 nm, whereas emitted fluorescence during excitation at 340 nm was unaffected. The lack of effect on fluorescence emission after excitation at 340 nm indicates that PbTx-2 did not produce significant cell swelling in neocortical neurons. The in situ SBFI calibrations revealed that the basal [Na ϩ ] i concentration in DIV 9 cerebrocortical neurons was 10.3 Ϯ 0.22 mM. This value is in agreement with the 8.9 mM concentration determined in cultured hippocampal neurons (DIV 14 -21) (Rose and Ransom, 1997) . This basal level of [Na ϩ ] was decreased slightly, although significantly (P Ͻ 0.05), by exposure to 1 M tetrodotoxin, to a value of 9.37 Ϯ 0.17 mM.
All sodium channel gating modifier compounds tested produced a rapid and concentration-dependent elevation in neuronal [Na ϩ ] i (Fig. 4, a-j) . The increment in [Na ϩ ] i exceeded 40 mM at high concentrations of PbTx-1 (100 nM), PbTx-2 (1 M), PbTx-3 (1 M), PbTx-desoxydioxolane (1 M), batrachotoxin (100 nM), and antillatoxin (1 M). The maximal increments in neuronal [Na ϩ ] i produced by PbTx-3␣-naphthoate, veratridine, aconitine, deltamethrin, and gambierol were somewhat lower, with maximal increments of less than 40 mM. Among the neurotoxin site 2 and site 5 compounds depicted in Fig. 4 , aconitine displayed the lowest efficacy, with maximal increments of [Na ϩ ] i of less than 15 mM ( Fig.  4j ) (for gambierol time-response data, see Fig. 8a ). The distinct efficacies of the array of gating modifier toxins examined are illustrated in Fig. 5 , depicting the concentrationresponse data fit by a three-parameter logistic equation. These data indicate that the relative efficacies of sodium channel gating modifiers as stimulators of Na ϩ influx differ substantially. The relative potencies (EC 50 values) and efficacies of all compounds tested are summarized in Table 1 . PbTx-1 was the most efficacious compound, with PbTx-desoxydioxolane, batrachotoxin, and antillatoxin having comparable maximal responses. The rank order of efficacy of sodium channel gating modifiers was PbTx-1 Ͼ PbTxdesoxydioxolane Ͼ batrachotoxin Ͼ antillatoxin Ͼ PbTx-2 ϭ PbTx-3 Ͼ PbTx-3␣-naphthoate Ͼ veratridine Ͼ deltamethrin Ͼ aconitine Ͼ gambierol. The relative efficacies of the site 2 compounds batrachotoxin, veratridine, and aconitine are congruent with those originally reported by Catterall (1977a,b) , in which batrachotoxin was characterized as a full agonist, and veratridine and aconitine were characterized as partial agonists at this site.
Although all of the [Na ϩ ] i responses to gating modifier compounds reported herein were derived from DIV 7 to 9 cerebrocortical neurons, we have found robust responses to these compounds as early as DIV 2. Both PbTx-2 and antillatoxin evoke maximal [Na ϩ ] i responses in DIV 2 cerebrocortical neurons that are comparable with those found in DIV 7 to 9 neurons (data not shown).
TTX Antagonism of Sodium Channel Gating Modifier-Induced Elevation of [Na
To confirm the role of VGSCs in gating modifier-induced elevation of [Na ϩ ] i in neocortical neurons, we examined the influence of TTX (1 M) on this response. As shown in Fig. 6 , the concentration-dependent increases in [Na ϩ ] i produced by antillatoxin, PbTx-2, veratridine, deltamethrin, aconitine, and gambierol were all abrogated by TTX. These data suggest that the observed gating modifier-induced elevation of [Na ϩ ] i is dependent on the activation of VGSCs. Due to the limited availability of the brevetoxin analogs, we only tested TTX with PbTx-2 inasmuch as this is the most abundant naturally occurring brevetoxin, and all brevetoxin analogs tested have been shown to inhibit the binding of [ 3 H]PbTx-3 to neurotoxin site 5 (Gawley et al., 1995; Michelliza S et al., 2007) .
Brevetoxin Enhancement of Deltamethrin-Induced Increase in [Na
؉ ] i . Although the multiple neurotoxin receptor sites on VGSCs are topologically distinct, there are strong allosteric interactions between them. Pyrethroids have been shown to increase the binding of [ 3 H]batrachotoxin to neurotoxin site 2 of VGSCs, and this effect is enhanced by brevetoxins interacting with neurotoxin site 5 (Lombet et al., 1988; Trainer et al., 1993; Li et al., 2001) . Therefore, we assessed the ability of a subthreshold concentration of PbTx-2 (10 nM) to enhance the effect of the pyrethroid deltamethrin on [Na ϩ ] i in neocortical neurons. As shown in Fig.  7 , a concentration of PbTx-2 (10 nM), which was inactive alone, produced a significant potentiation of deltamethrin (1 M)-induced elevation of [Na ϩ ] i . These data are consistent with the previously demonstrated positive allosteric interaction between the site 5 ligand brevetoxin and pyrethroids.
Inhibition of PbTx-1-Induced Increase in Neuronal [Na ؉ ] i by the Low-Efficacy Partial Agonist Gambierol. We have previously reported that gambierol binds to neurotoxin site 5 on the VGSC, albeit with modest affinity (K i ϭ 4.8 M) and acts as a functional antagonist of this site on neuronal VGSCs (LePage et al., 2007) . As depicted in Fig. 5 , gambierol acts as a low-efficacy partial agonist to stimulate Na ϩ influx in neocortical neurons. The time-response relationships for gambierol-induced elevation of neuronal [Na ϩ ] i are depicted in Fig. 8a . Inasmuch as the maximal increment in [Na ϩ ] i produced by gambierol was only 4 mM, this polyether ligand is less than 11% as effective as PbTx-1 as an activator of VGSCs. Given its low efficacy, we performed a titration with gambierol in the presence of a fixed concentration of the full agonist PbTx-1 (30 nM). As depicted in Fig. 8b,   Fig. 3 . Representative emitted fluorescence intensities before and after application of 300 nM PbTx-2. Emitted fluorescence during excitation at 340 nm (diamond) was insensitive to 300 nM PbTx-2 exposure, whereas emitted fluorescence during excitation at 380 nm (circle) decreased after application of 300 nM PbTx-2. Arrow, time of addition of PbTx-2. titration with gambierol produced a concentration-dependent reduction in the PbTx-1-induced integrated SBFI response. These data are consistent with gambierol and PbTx-1 interacting in a mutually exclusive manner with a common recognition site on VGSCs. A similar antagonistic effect for a low-efficacy agonist at neurotoxin site 2 has been demonstrated previously; aconitine, a low-efficacy agonist, was shown to inhibit the batrachotoxin-induced increase in Na ϩ permeability in neuroblastoma cells (Catterall, 1977a) . Considered together, these results demonstrate that the ability of 
Discussion
Based on the original work of Hodgkin and Huxley (1952) with squid axons, a single action potential was calculated to change minimally the Na ϩ electrochemical gradient (Hille, 1991) . However, the situation in mammalian neurons with fine axons, dendrites, and spines is much different due to greater surface/volume ratios. Thus, a single action potential may elevate [Na ϩ ] i substantially (Hille, 1991) . Using twophoton imaging to measure Na ϩ transients in spines and dendrites of CA 1 pyramidal neurons in hippocampal slices, Rose et al. (1999) demonstrated action potential-induced [Na ϩ ] i increments reached values of 3 to 4 mM after a train of just 20 action potentials. The influence of synaptic activity on [Na ϩ ] i in apical dendrites and spines was subsequently demonstrated in rat hippocampal slice preparations by Rose and Konnerth (2001) . These authors demonstrated that [Na ϩ ] i increased by 30 to 40 mM during short bursts of synaptic stimulation and reached 100 mM during a longterm potentiation protocol. The influence of [Na ϩ ] i dynamics on NMDA receptor function has been demonstrated in hippocampal neurons, where elevation of [Na ϩ ] i increased the open probability of NMDA receptors (Yu and Salter, 1998; Yu, 2006 ). An increment of [Na ϩ ] i of 10 mM was sufficient to produce significant increases in NMDA receptor single-channel activity. This Na ϩ -dependent regulation of NMDA receptor function was moreover shown to be controlled by Src family kinase-induced phosphorylation of the receptor (Yu and Salter, 1998; Yu, 2006) .
Lipid-soluble toxins acting at neurotoxin sites 2 and 5 have been shown to affect gating and to be allosterically coupled. Catterall has provided evidence that these neurotoxins induce conformational changes that alter the equilibrium between open and closed/inactivated states of the sodium channel (Catterall, 1977a (Catterall, ,b, 1980 . This work further indicated that the site 2 toxins aconitine, veratridine, grayanotoxin, and batrachotoxin act as full or partial agonists and cause persistent activation of sodium channels that can be quantitatively fit by an allosteric model (Catterall, 1977a (Catterall, , 1980 .
We have previously demonstrated that a group of site 5 ligands, including both naturally occurring and semisynthetic brevetoxin analogs, produce different maximal responses at saturating concentrations (LePage et al., 2003) . These previous studies used alterations in [Ca 2ϩ ] i in intact neurons to demonstrate that the brevetoxin PbTx-1 was a full agonist, whereas PbTx-3 and its analogs were partial agonists. In the present study, these data were extended by directly comparing the efficacies of an array of gating modifier toxins as stimulators of Na ϩ influx in cerebrocortical neurons. Measurement of [Na ϩ ] i transients in neocortical neurons represents a more direct measure of sodium channel activation than the [Ca 2ϩ ] i transients used previously (LePage et al., 2003) .
To explore the relative efficacies of gating modifier toxins, we used SBFI-loaded neocortical neurons to evaluate their respective concentration-response relationships. All neurotoxins tested evoked a rapid and concentration-dependent increase in neuronal [Na ϩ ] i . In agreement with the original observations of Catterall (1975) and Catterall et al. (1978) , our results with the site 2 activators batrachotoxin, veratridine, and aconitine indicate that these compounds produce concentration-dependent elevations of [Na ϩ ] i in neocortical neurons, with markedly distinct efficacies. Veratridine and aconitine were partial agonists, whereas batrachotoxin acted as a full agonist at neurotoxin site 2 in neocortical neurons. The naturally occurring brevetoxins PbTx-1, PbTx-2, and PbTx-3 also produced rapid and concentration-dependent increments in [Na ϩ ] i , with PbTx-1 proving to be the most potent and efficacious toxin. The primacy of PbTx-1 as an activator of Na ϩ influx in neocortical neurons suggests that this compound is a full agonist at neurotoxin site 5. The lower maximal responses to PbTx-2 and PbTx-3, accordingly, suggest that these compounds are partial agonists at neurotoxin site 5, inasmuch as a previous study has shown that all three toxins interact with the VGSC in a mutually exclusive manner (Gawley et al., 1995) . The greater efficacy of PbTx-1 at neurotoxin site 5 relative to other naturally occurring brevetoxins accords with the results of Trainer et al. (1993) , who showed PbTx-1 to be the most effective brevetoxin in enhancing the binding of [ 3 H]batrachotoxin to rat brain VGSCs. It has been suggested that the greater conformational flexibility in the backbone structure of PbTx-1compared with that of PbTx-2 may underlie its efficacy as a modulator of [ 3 H]batrachotoxin binding to neurotoxin site 2 (Cestèle et al., 1995) . The present results with the brevetoxin analog PbTx-3␣-naphthoate are also in agreement with our earlier studies at ASPET Journals on July 9, 2017 jpet.aspetjournals.org Downloaded from monitoring brevetoxin-induced Ca 2ϩ influx in cerebellar granule neurons in that this compound acts as a partial agonist in stimulating Na ϩ influx in neocortical neurons (LePage et al., 2003) . The brevetoxin analog PbTx-desoxydioxolane displayed an efficacy comparable with that of PbTx-1 but was more than 15-fold less potent.
In addition to the demonstration of partial agonism of site 2 and site 5 gating modifiers, we now report that antillatoxin has an efficacy at VGSCs that is comparable with PbTx-2 and PbTx-3. Antillatoxin-induced neurotoxicity and Ca 2ϩ influx are abrogated by tetrodotoxin, indicating that this compound is an activator of VGSCs (Li et al., 2001 ). The ability of antillatoxin to activate VGSCs was directly demonstrated by the TTX-sensitive stimulation of 22 Na ϩ influx in cerebellar granule neurons (Li et al., 2001) . These results were confirmed and extended in the present report, showing that antillatoxin is a potent and efficacious stimulator of [Na ϩ ] i transients in neocortical neurons. Its efficacy was comparable with that of the site 5 ligands PbTx-2 and PbTx-3. Moreover, the EC 50 value of antillatoxin of 78.9 nM was similar to the previously reported value of 98.2 nM as a stimulator of 22 Na ϩ influx. Therefore, antillatoxin seems to represent a novel activator of VGSCs whose site of action remains to be established (Li et al., 2001) .
Pyrethroids are synthetic insecticide compounds that resemble the natural pyrethrin toxins. Their primary molecular target as insecticides and neurotoxins is the VGSC (Trainer et al., 1997) . Pyrethroids such as deltamethrin shift the VGSC activation voltage to more negative values and inhibit inactivation. These activities result in a persistent activation of VGSCs as reflected in an enhancement of 22 Na ϩ influx similar to other gating modifiers (Lombet et al., 1988) . We demonstrate here that deltamethrin produces a concentration-dependent stimulation of Na ϩ influx in neocortical neurons, with an efficacy of 0.53.
The lowest efficacy neurotoxin evaluated was gambierol (efficacy ϭ 0.11). Gambierol is a polyether ladder toxin derived from the marine dinoflagellate G. toxicus, which also produces the potent site 5 activator ciguatoxin (LePage et al., 2005 (LePage et al., , 2007 . Gambierol has been shown to block voltagegated K ϩ channels at depolarized membrane potentials under voltage-clamp conditions in Xenopus oocytes (Cuypers et al., 2008) . However, whether the development of K ϩ channel block by gambierol requires depolarizing steps remains to be determined. At the resting membrane potential of cerebellar granule cells, we have shown previously that, unlike ciguatoxin, gambierol has no effect on intracellular Ca 2ϩ concentration and is without neurotoxic action in these cells (LePage et al., 2007) . By directly monitoring [Na ϩ ] i transients in the present studies, we have found gambierol to be a low-efficacy activator of VGSCs. These data are in agreement with those of Louzao et al. (2006) , who showed that gambierol acts as a partial agonist at site 5 of VGSCs in a neuroblastoma cell line. The involvement of neurotoxin site 5 in the Na ϩ influx produced by gambierol reported herein was demonstrated by the ability of gambierol to produce a concentration-dependent inhibition of PbTx-1-induced elevation of [Na ϩ ] i in neocortical neurons. These data parallel the original observations of Catterall (1977a) demonstrating partial agonism at neurotoxin site 2 in that treatment of cells with a combination of a good activator (batrachotoxin) and a poor activator (aconitine) resulted in an inhibition of the response to the good activator by the poor activator. Thus, a low-efficacy agonist can be treated as an inhibitor of a highefficacy agonist. Therefore, our demonstration of gambierol inhibition of PbTx-1-induced Na ϩ influx parallels the earlier findings of Catterall and further demonstrates that the ability of neurotoxins to act as partial agonists is shared by compounds acting at neurotoxin sites 2 and 5. An additional parallel for sites 2 and 5 gating modifier compounds documented herein is in regards to the maximal increment in [Na ϩ ] i produced by the respective full agonists, batrachotoxin and PbTx-1. The similarity in the maximal responses to batrachotoxin and PbTx-1 may reflect the partial overlap of neurotoxin sites 2 and 5 on S6 segments of the VGSC ␣-subunit (Wang and Wang, 2003) . Receptor mapping studies have found that both site 2 and site 5 ligands interact with residues in the S6 segments of domain I on the VGSC ␣-subunit (Wang and Wang, 2003) .
Thus, when considered together, the lipophilic gating modifier toxins (brevetoxins, batrachotoxin, veratridine, aconitine, gambierol, and deltamethrin) as well as the novel lipopeptide antillatoxin are all capable of exerting a TTXsensitive elevation of [Na ϩ ] i in neocortical neurons. Although these sodium channel activators display differing efficacies, they are all able to produce [Na ϩ ] i increments of 4 to 60 mM. Therefore, these [Na ϩ ] i increments are sufficient to increase NMDA receptor channel activity. Sodium channel gating modifier toxins are all potentially capable of up-regulating NMDA receptor signaling (Dravid et al., 2005) . 
